Home » Topics » BioWorld Science

BioWorld Science
RSS

Dart NeuroScience discloses PDE7B inhibitors

Feb. 4, 2019

GenSight announces 48-week data from RESCUE trial of GS-010 in LHON

Feb. 4, 2019

FDA issues complete response letter for ALKS-5461 NDA for adjunctive treatment of MDD

Feb. 4, 2019

CSIC patents new PDE8A inhibitors

Feb. 4, 2019

Tripartite motif family-like 2 downregulation reduces oral squamous cell carcinoma growth

Feb. 4, 2019

Preclinical data presented on PBK-001 vaccine for the treatment of melioidosis

Feb. 4, 2019

Novel GPR40 superagonist demonstrates remarkable preclinical efficacy in models of diabetes

Feb. 4, 2019

SGL-5213 demonstrates efficacy in preclinical model of impaired glucose tolerance

Feb. 4, 2019

Protein links sleep and sickness

Feb. 4, 2019

Motor protein myosin drives metastasis

Feb. 4, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...